Antibiotics currently in the clinical pipeline are still "inefficient" against the increasing prevalence of antimicrobial resistance, according to the World Health Organization's 2023 report on antibacterial agents in clinical and preclinical development, published June 14.

Medicare beneficiaries can now enroll in Amazon Pharmacy's RxPass medication prescription service, an Amazon Prime member benefit that offers access to dozens of commonly prescribed medications for $5 a month. 

The FDA has placed clinical holds on three trials run by Zentalis Pharmaceuticals after two study participants died, the biopharmaceutical company said June 18. 

Since 2020, drug shortage durations have increased by one year, with the average shortage lasting 3.3 years, according to U.S. Pharmacopoeia.

Spending on drugs purchased at discounted 340B prices across all participating facilities went up 19% annually between 2010 and 2021, according to a June 17 report from the Congressional Budget Office. 

On June 17, Merck received FDA approval for a vaccine designed to protect adults from pneumococcus, a type of bacteria that can cause serious disease, including pneumonia. 

The Missouri State Senate passed a bill, June 14, that will forbid drugmakers from restricting the distribution of 340B drugs to contract pharmacies. The bill will either be signed by the governor by July 14, vetoed, or it will become law as of Aug. 28 without his signature, according to a June 14 senate update.

The FDA approved AstraZeneca's monotherapy for endometrial cancer, Imfinzi, after it was found in a study to decrease its risk of progression and death by 58% in patients who were diagnosed with advanced or recurrent endometrial cancer that is mismatch repair deficient.

As nearly 10 million people in the eastern U.S. feel a major heat wave this week, patients taking some medications have a higher risk of heat-related illnesses, The New York Times reported June 15. 

Vermont Sen. Bernie Sanders has canceled a Senate committee vote that would have determined whether to subpoena Novo Nordisk executives about the cost of the drugmaker's blockbuster drugs, Ozempic and Wegovy. The move comes as Novo Nordisk's CEO agreed to participate in a Senate committee hearing set for September. 

It's unclear how much Mark Cuban can or will disrupt the pharmaceutical industry, but he told The Athletic he's in the business for the long haul.

Pfizer's gene therapy candidate for Duchenne muscular dystrophy failed to meet its primary endpoint in a phase 3 trial, the company said June 12. 

When Houston Methodist installed Amazon Echo Dots in its pharmacies and patient rooms, the system halved the time it takes for orders to be signed and medications to be administered by nurses, according to Pharmacy Practice News. 

Contaminated manufacturing may be what has led generic drugs at CVS to be recalled almost twice as often as generic drugs at Walgreens or Walmart, according to a June 10 report from Bloomberg.

A workplace and well-being report has unveiled a new problem in pharmacies: outdated software and broken computer systems. 

A bipartisan group of 32 attorneys general is urging the Supreme Court to grant them more regulatory power over pharmacy benefit managers. 

AdventHealth Shawnee Mission in Merriam, Kan., announced a $35,000 partnership with Pharmacy of Grace, a nonprofit in the Kansas City metropolitan area that provides pharmacy services to uninsured or underinsured patients.

Team Cuban Card, an offering from Mark Cuban Cost Plus Drug Co., is now accepted at Food Lion, Giant Food, Hannaford and Stop & Shop. 

Tirzepatide, the main ingredient for Eli Lilly's Mounjaro and Zepbound, omitted the presence of metabolic dysfunction-associated steatohepatitis in a phase 2 study, the drugmaker said June 8. The trial results could precede another indication for the popular drugs. 

On June 10, a panel of FDA advisors voted 11-0 in favor of donanemab, an experimental Alzheimer's disease treatment from Eli Lilly.